The number of victims and coronary victims worldwide

More than 18 and a half million people have been diagnosed with the new coronary and 700 thousand of them have lost their lives these months. The United States, Brazil, India and Mexico lead the number of victims that are increasing by 5,900 per day on average.

The new Coronavirus on Wednesday increased the balance of victims worldwide to 700 thousand.

Based on American university records “Johns Hopkins”, the infection at 8 months has affected 18 and a half million people, of whom over 11 million have managed to recover.

The number of new cases diagnosed with the new cod exceeded 400,000 per day, reports Ora News.

The United States of America ranks first in the size of the epidemic tragedy, with over 156 thousand lives lost and nearly 5 million infected, followed by Brazil with about 3 million infected and more than 95 thousand lives lost.

These two countries are followed by Mexico with 48800 victims and Great Britain, 46 thousand of them.

India, Russia and South Africa complement the first five countries for the largest number of cases.

China, the initial outbreak, reported on Wednesday only 27 new patients with the 19th ward, confirming a total of 84 thousand people since last quarter and 4,600 victims.

In other European countries, the German doctors' union said on Tuesday that Germany is experiencing the second wave of the coronary pandemic, while in France, the government's scientific council warned that the country could lose control of the new individual infection.

The prime ministers of the continent's top states have instructed their citizens not to let down alertness and to continue fighting the virus at the state, local and institutional level.

In the US, President Donald Trump's administration is considering reopening schools during the autumn as long as students respect hygiene and social distance rules.

On the front of the vaccines, meanwhile, the American company Novavax announced that an experimental product against the 19 strong immune reaction with the production of more antibodies to fight infection in patients.

The last phase of clinical testing is set to take place in autumn, and if it turns positive, more than 100 million doses of the vaccine can be produced in 2021.